0,952  0,004  Apoptosis agonist
0,926  0,002  Caspase 9 stimulant
0,926  0,004  Transcription factor NF kappa B inhibitor
0,924  0,005  Antiinflammatory
0,918  0,003  Chemopreventive
0,874  0,005  Antineoplastic (lung cancer)
0,870  0,001  Phosphorylase inhibitor
0,849  0,004  Nitric oxide antagonist
0,837  0,004  Antineoplastic (melanoma)
0,830  0,007  Antineoplastic (breast cancer)
0,812  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,812  0,002  Phospholipase C inhibitor
0,809  0,004  Hepatic disorders treatment
0,809  0,008  TNF expression inhibitor
0,792  0,005  Antineoplastic (ovarian cancer)
0,788  0,003  Hepatoprotectant
0,786  0,007  Antileukemic
0,781  0,008  Antidiabetic
0,781  0,008  Cyclophilin D inhibitor
0,767  0,005  Prostate cancer treatment
0,762  0,004  Antineoplastic (pancreatic cancer)
0,759  0,002  Antineoplastic (endocrine cancer)
0,749  0,003  Protein-tyrosine phosphatase 1B inhibitor
0,740  0,004  Antipyretic
0,736  0,005  5 Hydroxytryptamine release stimulant
0,728  0,003  Protein-tyrosine phosphatase inhibitor
0,721  0,002  AMP-activated protein kinase stimulant
0,714  0,005  Caspase 3 stimulant
0,720  0,013  Antineoplastic (colorectal cancer)
0,714  0,013  Antineoplastic (colon cancer)
0,696  0,004  Apoptosis antagonist
0,688  0,003  ICAM1 expression inhibitor
0,688  0,003  Insulin secretagoues
0,683  0,001  Interferon gamma antagonist
0,681  0,011  Chemoprotective
0,669  0,005  Antineoplastic (multiple myeloma)
0,666  0,007  AR expression inhibitor
0,659  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,628  0,011  Antineoplastic (cervical cancer)
0,622  0,007  Hypoglycemic
0,609  0,002  Contraceptive female
0,615  0,009  Antidiabetic (type 2)
0,604  0,003  Insulin sensitizer
0,641  0,045  Alpha-glucosidase inhibitor
0,601  0,009  Antineoplastic (glioma)
0,596  0,005  Antihypoxic
0,593  0,005  Antihypertriglyceridemic
0,596  0,011  NOS2 expression inhibitor
0,601  0,016  Vasodilator, peripheral
0,601  0,018  Cholesterol antagonist
0,595  0,012  Cytotoxic
0,580  0,007  Vascular (periferal) disease treatment
0,576  0,004  Antiviral (Influenza A)
0,585  0,012  Antioxidant
0,576  0,004  Antiviral (Influenza)
0,579  0,019  Immunostimulant
0,569  0,017  Sensitization
0,564  0,012  Antineoplastic (brain cancer)
0,561  0,014  Cardioprotectant
0,548  0,003  Cyclooxygenase 3 inhibitor
0,538  0,006  Diuretic
0,552  0,021  Antihypercholesterolemic
0,536  0,007  Wound healing agent
0,537  0,009  Antineoplastic (glioblastoma multiforme)
0,504  0,003  Gastrin inhibitor
0,498  0,006  Antiviral (Hepatitis)
0,503  0,015  Cardiodepressant
0,496  0,018  Metabolic disease treatment
0,498  0,028  Bone diseases treatment
0,473  0,009  Antiviral (HIV)
0,465  0,003  Cholesterol synthesis inhibitor
0,485  0,023  Lipoprotein disorders treatment
0,466  0,005  Antiviral (Hepatitis B)
0,468  0,013  Antineoplastic (liver cancer)
0,460  0,008  Contraceptive
0,470  0,024  NOS3 expression inhibitor
0,453  0,009  Abortion inducer
0,457  0,014  Antineoplastic (renal cancer)
0,476  0,038  Atherosclerosis treatment
0,450  0,020  UGT2B4 substrate
0,431  0,003  Inducible nitric-oxide synthase inhibitor
0,429  0,012  UGT1A4 substrate
0,442  0,029  Antiosteoporotic
0,425  0,016  Antiulcerative
0,426  0,026  Antiprotozoal (Leishmania)
0,401  0,007  Antiviral (Hepatitis C)
0,407  0,018  Antineoplastic (lymphocytic leukemia)
0,392  0,006  Acute respiratory distress syndrome (ARDS) treatment
0,402  0,016  Sodium/bile acid cotransporter inhibitor
0,425  0,043  Antithrombotic
0,395  0,019  Transcription factor STAT3 inhibitor
0,381  0,009  Liver fibrosis treatment
0,384  0,012  Prostate disorders treatment
0,375  0,003  Transcription factor NF kappa B stimulant
0,429  0,061  Histamine release inhibitor
0,377  0,011  Lipid peroxidase inhibitor
0,381  0,016  Antiviral (Herpes)
0,374  0,015  Platelet adhesion inhibitor
0,414  0,058  Immunosuppressant
0,375  0,019  Antihelmintic
0,379  0,025  Angiogenesis stimulant
0,386  0,033  Carcinogenic
0,381  0,029  Hypolipemic
0,365  0,015  Skin whitener
0,355  0,006  Expectorant
0,410  0,062  Antipruritic, allergic
0,373  0,029  Antiparasitic
0,352  0,015  Antiacne
0,353  0,017  UGT2B7 substrate
0,341  0,005  Antiinfertility, female
0,366  0,034  Tumour necrosis factor alpha release inhibitor
0,357  0,025  UDP-glucuronosyltransferase substrate
0,338  0,011  Diabetic nephropathy treatment
0,338  0,011  Antihelmintic (Nematodes)
0,338  0,015  Lipocortins synthesis antagonist
0,330  0,010  Phospholipase A2 inhibitor
0,338  0,017  Melanin inhibitor
0,335  0,015  Hair growth stimulant
0,333  0,013  Protein kinase stimulant
0,331  0,018  Antineoplastic (squamous cell carcinoma)
0,329  0,019  Prostatic (benign) hyperplasia treatment
0,349  0,043  Antineoplastic (non-small cell lung cancer)
0,324  0,019  Antineoplastic (carcinoma)
0,345  0,040  Proliferative diseases treatment
0,385  0,084  Antibacterial
0,299  0,003  Diacylglycerol O-acyltransferase inhibitor
0,332  0,038  Vasodilator
0,350  0,060  Antifungal
0,337  0,052  Interleukin 2 agonist
0,330  0,045  Renal disease treatment
0,298  0,015  Interleukin 6 antagonist
0,340  0,060  Antipsoriatic
0,283  0,004  CD45 antagonist
0,283  0,005  HDL-cholesterol increasing
0,282  0,011  Antitussive
0,311  0,049  Free radical scavenger
0,292  0,034  UGT1A1 substrate
0,305  0,053  Transcription factor STAT inhibitor
0,256  0,012  Antihemorrhagic
0,253  0,010  Anticataract
0,289  0,047  Antineoplastic (sarcoma)
0,246  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,273  0,035  Non-steroidal antiinflammatory agent
0,245  0,012  Antinephritic
0,311  0,079  Vasodilator, coronary
0,250  0,020  UGT2B9 substrate
0,247  0,017  DNA polymerase I inhibitor
0,273  0,043  Fibrosis treatment
0,327  0,099  Antiobesity
0,282  0,057  Myocardial infarction treatment
0,256  0,035  Neurotrophic factor enhancer
0,340  0,126  Antiarthritic
0,212  0,001  Heme oxygenase stimulant
0,229  0,033  UGT2B15 substrate
0,202  0,007  Antiprotozoal (Toxoplasma)
0,194  0,002  Cholesterol ester transfer protein antagonist
0,251  0,061  UGT1A6 substrate
0,216  0,027  UGT2B10 substrate
0,184  0,005  Lanosterol 14 alpha demethylase inhibitor
0,206  0,027  Arachidonic acid antagonist
0,194  0,019  Beta amyloid protein antagonist
0,180  0,007  Anabolic
0,189  0,017  Potassium channel (Ca-activated) activator
0,187  0,020  Choleretic
0,173  0,007  CC chemokine 6 receptor antagonist
0,185  0,022  Adenylate cyclase stimulant
0,218  0,054  P-glycoprotein inhibitor
0,182  0,019  Protease inhibitor
0,167  0,005  Aldosterone antagonist
0,175  0,015  Nitric-oxide synthase inhibitor
0,160  0,005  Glycine receptor antagonist
0,182  0,028  Farnesoid X receptor antagonist
0,158  0,005  Na+ K+ transporting ATPase inhibitor
0,205  0,058  Antipruritic, non-allergic
0,236  0,102  CYP2C19 substrate
0,147  0,014  Antiviral (Rhinovirus)
0,141  0,009  Bile acid receptor antagonist
0,187  0,055  Antirickettsial
0,190  0,059  Antineoplastic (gastric cancer)
0,212  0,084  Antineoplastic (lymphoma)
0,151  0,024  Beta glucuronidase inhibitor
0,141  0,019  UGT2B11 substrate
0,143  0,023  Actinic keratosis treatment
0,188  0,068  Dual specificity phosphatase 3 inhibitor
0,145  0,025  Uric acid excretion stimulant
0,126  0,008  5-Alpha-reductase inhibitor
0,136  0,022  ABCA1 expression enhancer
0,154  0,046  Antihyperlipoproteinemic
0,112  0,005  RNA-directed RNA polymerase stimulant
0,152  0,046  Monophenol monooxygenase inhibitor
0,161  0,057  Antidiabetic (type 1)
0,199  0,095  Teratogen
0,194  0,092  Antineoplastic enhancer
0,113  0,012  CDC25B inhibitor
0,122  0,021  Contraceptive male
0,169  0,068  Thrombolytic
0,142  0,042  Gout treatment
0,145  0,045  Growth stimulant
0,221  0,122  Analeptic
0,109  0,012  Androgen agonist
0,142  0,046  Interleukin 1b antagonist
0,211  0,114  UGT1A9 substrate
0,121  0,025  Ornithine decarboxylase inhibitor
0,114  0,018  Potassium channel large-conductance Ca-activated activator
0,103  0,007  Nitric oxide donor
0,130  0,036  Antineoplastic antibiotic
0,126  0,034  Antiviral (SARS coronavirus)
0,126  0,034  Antiviral (Coronavirus)
0,111  0,022  Lipase inhibitor
0,166  0,078  Dual specificity phosphatase inhibitor
0,104  0,016  Anticholelithogenic
0,125  0,039  Chronic obstructive bronchitis treatment
0,133  0,049  Topoisomerase I inhibitor
0,108  0,027  3C-Like protease (SARS coronavirus) inhibitor
0,205  0,125  Antineoplastic (bladder cancer)
0,100  0,021  Glycine receptor agonist
0,230  0,151  CYP3A4 substrate
0,129  0,052  Microtubule formation inhibitor
0,080  0,005  Farnesoid X receptor agonist
0,154  0,080  UGT1A3 substrate
0,174  0,101  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,089  0,017  Transcription factor AP-1 inhibitor
0,222  0,151  Antineoplastic (osteosarcoma)
0,110  0,039  Androgen antagonist
0,267  0,198  Alzheimer's disease treatment
0,079  0,011  Acetyl-CoA transferase 2 inhibitor
0,072  0,005  Estrone sulfatase inhibitor
0,080  0,013  Lipocortins synthesis agonist
0,116  0,049  Xanthine oxidase inhibitor
0,133  0,067  Liver cirrhosis treatment
0,117  0,051  UGT2B1 substrate
0,102  0,038  Topoisomerase II alpha inhibitor
0,196  0,135  Respiratory analeptic
0,122  0,062  Alcohol dehydrogenase substrate
0,082  0,022  SULT2A1 substrate
0,123  0,064  Topoisomerase II inhibitor
0,138  0,078  Skeletal muscle relaxant
0,068  0,011  Cholesterol esterase inhibitor
0,158  0,100  LDLR expression enhancer
0,090  0,034  CDC25A inhibitor
0,117  0,064  Caspase 3 inhibitor
0,072  0,019  Postcoital contraceptive
0,163  0,110  Embryotoxic
0,079  0,028  Aromatase inhibitor
0,072  0,024  Acetyl-CoA transferase inhibitor
0,054  0,007  Tubulin agonist
0,055  0,009  Glucose-6-phosphate dehydrogenase inhibitor
0,071  0,026  Estrogen agonist
0,070  0,026  Postmenopausal disorders treatment
0,174  0,131  Cardiovascular analeptic
0,096  0,053  SULT1E1 substrate
0,058  0,017  Microtubule stabilization
0,054  0,016  Liver X receptor alpha agonist
0,100  0,063  Sulfotransferase substrate
0,055  0,018  Neuraminidase (Influenza A) inhibitor
0,048  0,012  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,059  0,025  Glucose-6-phosphate translocase inhibitor
0,035  0,002  Telomerase stimulant
0,123  0,092  Psychosexual dysfunction treatment
0,080  0,049  Keratolytic
0,113  0,085  Acetylcholinesterase inhibitor
0,090  0,063  Glutamate release inhibitor
0,107  0,081  Estrogen antagonist
0,040  0,014  HMG CoA reductase inhibitor
0,132  0,107  Ca2+-transporting ATPase inhibitor
0,066  0,041  Neuraminidase (influenza) inhibitor
0,064  0,040  Prostaglandin F2 alpha antagonist
0,030  0,007  Corticosteroid-like
0,043  0,021  Retinoic acid alpha receptor agonist
0,047  0,027  Estradiol 17 beta-dehydrogenase inhibitor
0,044  0,025  Heme oxygenase inhibitor
0,108  0,091  Alpha-N-acetylglucosaminidase inhibitor
0,028  0,011  Retinoid X gamma receptor agonist
0,039  0,022  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,080  0,063  Thioredoxin reductase inhibitor
0,030  0,014  1,3-Beta-glucan synthase inhibitor
0,029  0,015  Hedgehog signaling activator
0,105  0,092  Amylase inhibitor
0,025  0,011  Retinoic acid gamma receptor agonist
0,028  0,016  Retinoid X gamma receptor antagonist
0,023  0,011  5-Alpha-reductase 2 inhibitor
0,022  0,012  Retinoic acid alpha receptor antagonist
0,122  0,113  Antidiarrheal
0,034  0,026  p53 inhibitor
0,022  0,014  Retinoid X beta receptor agonist
0,019  0,012  Retinoic acid receptor antagonist
0,123  0,116  Growth hormone agonist
0,123  0,117  Muscle relaxant
0,022  0,017  Retinoic acid receptor agonist
0,020  0,014  Retinoic acid beta receptor agonist
0,039  0,034  Cholesterol absorption inhibitor
0,018  0,015  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,043  0,039  Parathyroid hormone antagonist
0,191  0,188  CTGF expression inhibitor
0,145  0,143  Antiparkinsonian, rigidity relieving
0,015  0,014  Vitamin D receptor agonist
0,039  0,038  Liver X receptor agonist
0,005  0,005  Transcortin receptor antagonist

